Asparaginase

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23

Among ALL survivors who were 15 years or older at diagnosis, every 1000 units/m2 increase in asparaginase dose increased the odds of developing drug-induced diabetes by 12%.

Effect: decline; OR 1.12 per 1000 units/m2; CI: 95% CI 1.02-1.23